NextCure Inc（NXTC）價格預測

$6.800

+0.437 (+6.42%)收盤時

價格預測

1-Day Price Prediction

+1.98%

1-Week Prediction

-3.71%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

NXTC 相似圖表分析預測

Alphio's NXTC stock price prediction model matches the current NextCure Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.93 (+1.98%). The 1-week path is $6.55 (-3.71%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 NextCure Inc 股票嗎？

NextCure Inc. is a good buy right now due to its current price of $6.09, which is significantly lower than the analyst target of $25, indicating a potential upside of over 300%. Additionally, the recent merger with Avere Therapeutics is expected to enhance its market position and funding for clinical trials, which could drive future growth. However, the company has reported a negative net income of $14,892,000 for Q2 2026, which is a risk to consider.

NXTC 股價於 Tuesday 收在 $6.80，此前上漲 +6.42%

NextCure Inc (NXTC) last closed at $6.8, gaining +6.42%. These facts feed the 1-day and 1-week NXTC price prediction above.

預測驅動因素

NextCure Inc（NXTC）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似圖表形態

近期走勢與 NXTC 最接近的股票，依相似度排序。

OPLN

91.28%

+13.91%

AMRX

91.02%

+48.00%

PZZA

90.66%

-14.98%

WBD

90.17%

-4.82%

AUPH

90.08%

-11.47%

NXTC 季節性分析

Historically the probability of a positive September return for NXTC is 47.62%. November offers the highest probability of a positive month at 74.36%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…